Skip to content

Long-term outcomes of assertive community treatment in Japan: 7-year follow-up of a randomized controlled trial

Long-term outcomes of assertive community treatment in Japan: 7-year follow-up of a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1030250281
Enrollment
161
Registered
2025-08-05
Start date
2021-05-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, delusional disorder, mood disorder, or other psychiatric conditions, Severe mental Illness

Interventions

Nothing

Sponsors

Satake Naoko
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The subjects were 43 people who participated in a pilot study of ACT support and 118 people who participated in a randomized controlled trial (RCT) as part of the Ministry of Health, Labour and Welfare Sciences Research Grant-funded Mental Health Science Project, "Research on the Development of a New Home-Visiting Comprehensive Community Living Support Service System for Persons with Severe Mental Illnesses" (FY2002-FY2004) (a total of 161 people).

Exclusion criteria

Exclusion criteria: Nothing paticular

Design outcomes

Primary

MeasureTime frame
Frequency of hospitalization, length of hospitalization, use of psychiatric services (outpatient, interruption, emergency use), drug treatment details, arrest or detention, use of community welfare services (what services were used and for how long), employment status (whether employed or not)

Secondary

MeasureTime frame
Continuation of ACT use, dropout rate, and reasons for dropout for the ACT users

Contacts

Public ContactNaoko Satake

National Kohnodai Medical Center, Japan Institute for Health Security

satake.n@jihs.go.jp+81-47-372-3501

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026